Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The Ras-related gene ERAS is involved in human and murine breast cancer.

Suárez-Cabrera C, de la Peña B, González LL, Page A, Martínez-Fernández M, Casanova ML, Paramio JM, Rojo-Sebastián A, Moreno-Bueno G, Maroto A, Ramírez Á, Navarro M.

Sci Rep. 2018 Aug 29;8(1):13038. doi: 10.1038/s41598-018-31326-4.

2.

Correction: Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer.

Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez-Cabrera C, Fernández MG, Mérida JR, Paramio JM, García-Fernández RA, Fernández-Aceñero MJ, Casanova ML.

Oncotarget. 2017 Aug 7;8(32):53886. doi: 10.18632/oncotarget.20001. eCollection 2017 Aug 8.

3.

IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent.

Page A, Bravo A, Suarez-Cabrera C, Alameda JP, Casanova ML, Lorz C, Segrelles C, Segovia JC, Paramio JM, Navarro M, Ramirez A.

Mol Cancer Res. 2017 Sep;15(9):1255-1264. doi: 10.1158/1541-7786.MCR-17-0157. Epub 2017 Jun 5.

4.

Correction: Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53.

Page A, Navarro M, Suarez-Cabrera C, Alameda JP, Casanova ML, Paramio JM, Bravo A, Ramirez A.

Oncotarget. 2017 Mar 28;8(13):22304. doi: 10.18632/oncotarget.16592. No abstract available.

5.

A Transposon-based Analysis Reveals RASA1 Is Involved in Triple-Negative Breast Cancer.

Suárez-Cabrera C, Quintana RM, Bravo A, Casanova ML, Page A, Alameda JP, Paramio JM, Maroto A, Salamanca J, Dupuy AJ, Ramírez A, Navarro M.

Cancer Res. 2017 Mar 15;77(6):1357-1368. doi: 10.1158/0008-5472.CAN-16-1586. Epub 2017 Jan 20.

6.

Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer.

Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez-Cabrera C, Fernández MG, Mérida JR, Paramio JM, García-Fernández RA, Fernández-Aceñero MJ, Casanova ML.

Oncotarget. 2016 May 17;7(20):29531-47. doi: 10.18632/oncotarget.8792. Erratum in: Oncotarget. 2017 Aug 7;8(32):53886.

7.

Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53.

Page A, Navarro M, Suarez-Cabrera C, Alameda JP, Casanova ML, Paramio JM, Bravo A, Ramirez A.

Oncotarget. 2016 Apr 12;7(15):20902-18. doi: 10.18632/oncotarget.7897. Erratum in: Oncotarget. 2017 Mar 28;8(13):22304.

8.

Long-Term Follow-Up of Proteinuria and Estimated Glomerular Filtration Rate in HIV-Infected Patients with Tubular Proteinuria.

Peyriere H, Cournil A, Casanova ML, Badiou S, Cristol JP, Reynes J.

PLoS One. 2015 Nov 16;10(11):e0142491. doi: 10.1371/journal.pone.0142491. eCollection 2015.

9.

Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.

Carra-Dalliere C, Menjot de Champfleur N, Deverdun J, Ayrignac X, Nerrant E, Makinson A, Casanova ML, Labauge P.

J Neuroradiol. 2016 Feb;43(1):6-10. doi: 10.1016/j.neurad.2015.08.001. Epub 2015 Oct 23.

10.

Monoclonal Gammopathy in HIV-1-Infected Patients: Factors Associated With Disappearance Under Long-Term Antiretroviral Therapy.

Casanova ML, Makinson A, Eymard-Duvernay S, Ouedraogo DE, Badiou S, Reynes J, Tuaillon E.

J Acquir Immune Defic Syndr. 2015 Nov 1;70(3):250-5. doi: 10.1097/QAI.0000000000000708.

PMID:
26039930
11.

Recent HIV infection complicated with leukocytoclastic vasculitis and oligoarthritis.

Viala B, Leblay P, Casanova ML, Jorgensen C, Pers YM.

Med Mal Infect. 2014 Jun;44(6):284-5. doi: 10.1016/j.medmal.2014.04.006. Epub 2014 Jun 6. No abstract available.

PMID:
24913830
12.

RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter.

Moreno-Maldonado R, Murillas R, Navarro M, Page A, Suarez-Cabrera C, Alameda JP, Bravo A, Casanova ML, Ramirez A.

ScientificWorldJournal. 2014 Jan 12;2014:193803. doi: 10.1155/2014/193803. eCollection 2014.

13.

Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy.

Ouedraogo DE, Makinson A, Vendrell JP, Casanova ML, Nagot N, Cezar R, Bollore K, Al Taaba Y, Foulongne V, Badiou S, Viljoen J, Reynes J, Van de Perre P, Tuaillon E.

Blood. 2013 Oct 24;122(17):3030-3. doi: 10.1182/blood-2012-12-470393. Epub 2013 Aug 12.

14.

Functional inactivation of CYLD promotes the metastatic potential of tumor epidermal cells.

Alameda JP, Fernández-Aceñero MJ, Quintana RM, Page A, Ramírez Á, Navarro M, Casanova ML.

J Invest Dermatol. 2013 Jul;133(7):1870-8. doi: 10.1038/jid.2013.76. Epub 2013 Feb 20.

15.

A transposon-based analysis of gene mutations related to skin cancer development.

Quintana RM, Dupuy AJ, Bravo A, Casanova ML, Alameda JP, Page A, Sánchez-Viera M, Ramírez A, Navarro M.

J Invest Dermatol. 2013 Jan;133(1):239-48. doi: 10.1038/jid.2012.245. Epub 2012 Jul 26.

16.

CYLD regulates keratinocyte differentiation and skin cancer progression in humans.

Alameda JP, Fernández-Aceñero MJ, Moreno-Maldonado R, Navarro M, Quintana R, Page A, Ramírez A, Bravo A, Casanova ML.

Cell Death Dis. 2011 Sep 8;2:e208. doi: 10.1038/cddis.2011.82.

17.

IKKβ overexpression leads to pathologic lesions in stratified epithelia and exocrine glands and to tumoral transformation of oral epithelia.

Page A, Cascallana JL, Casanova ML, Navarro M, Alameda JP, Pérez P, Bravo A, Ramírez A.

Mol Cancer Res. 2011 Oct;9(10):1329-38. doi: 10.1158/1541-7786.MCR-11-0168. Epub 2011 Aug 5.

18.

Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors.

Alameda JP, Moreno-Maldonado R, Fernández-Aceñero MJ, Navarro M, Page A, Jorcano JL, Bravo A, Ramírez Á, Casanova ML.

PLoS One. 2011;6(7):e21984. doi: 10.1371/journal.pone.0021984. Epub 2011 Jul 6.

19.

An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells.

Alameda JP, Moreno-Maldonado R, Navarro M, Bravo A, Ramírez A, Page A, Jorcano JL, Fernández-Aceñero MJ, Casanova ML.

Oncogene. 2010 Dec 16;29(50):6522-32. doi: 10.1038/onc.2010.378. Epub 2010 Sep 13.

PMID:
20838385
20.

IKKbeta leads to an inflammatory skin disease resembling interface dermatitis.

Page A, Navarro M, Garín M, Pérez P, Casanova ML, Moreno R, Jorcano JL, Cascallana JL, Bravo A, Ramírez A.

J Invest Dermatol. 2010 Jun;130(6):1598-610. doi: 10.1038/jid.2010.28. Epub 2010 Mar 4.

21.

Rescue of atypical protein kinase C in epithelia by the cytoskeleton and Hsp70 family chaperones.

Mashukova A, Oriolo AS, Wald FA, Casanova ML, Kröger C, Magin TM, Omary MB, Salas PJ.

J Cell Sci. 2009 Jul 15;122(Pt 14):2491-503. doi: 10.1242/jcs.046979. Epub 2009 Jun 23.

22.

Intermediate filaments interact with dormant ezrin in intestinal epithelial cells.

Wald FA, Oriolo AS, Casanova ML, Salas PJ.

Mol Biol Cell. 2005 Sep;16(9):4096-107. Epub 2005 Jun 29.

23.

Epidermal abnormalities and increased malignancy of skin tumors in human epidermal keratin 8-expressing transgenic mice.

Casanova ML, Bravo A, Martínez-Palacio J, Fernández-Aceñero MJ, Villanueva C, Larcher F, Conti CJ, Jorcano JL.

FASEB J. 2004 Oct;18(13):1556-8. Epub 2004 Aug 19.

PMID:
15319370
24.

Effects of developer depletion on image quality of Kodak Insight and Ektaspeed Plus films.

Casanova MS, Haiter-Neto F.

Dentomaxillofac Radiol. 2004 Mar;33(2):108-13. Erratum in: Dentomaxillofac Radiol. 2004 Sept;33(5):354. Casanova, ML [corrected to Casanova, MS].

PMID:
15314003
25.

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M.

Cancer Res. 2004 Aug 15;64(16):5617-23.

26.

Inhibition of tumor angiogenesis by cannabinoids.

Blázquez C, Casanova ML, Planas A, Gómez Del Pulgar T, Villanueva C, Fernández-Aceñero MJ, Aragonés J, Huffman JW, Jorcano JL, Guzmán M.

FASEB J. 2003 Mar;17(3):529-31. Epub 2003 Jan 2.

PMID:
12514108
27.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández-Aceñero MJ, Huffman JW, Jorcano JL, Guzmán M.

J Clin Invest. 2003 Jan;111(1):43-50.

28.

Abnormal cochlea linked to deafness in transgenic mice expressing human cytokeratin K8.

Bartolomé MV, Casanova ML, Carricondo F, del Castillo E, Jorcano JL, Gil-Loyzaga P.

Histol Histopathol. 2002;17(3):827-36. doi: 10.14670/HH-17.827.

PMID:
12168793
29.

A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.

Casanova ML, Larcher F, Casanova B, Murillas R, Fernández-Aceñero MJ, Villanueva C, Martínez-Palacio J, Ullrich A, Conti CJ, Jorcano JL.

Cancer Res. 2002 Jun 15;62(12):3402-7.

30.

Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation.

Paramio JM, Segrelles C, Casanova ML, Jorcano JL.

J Biol Chem. 2000 Dec 29;275(52):41219-26.

31.

Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8.

Casanova ML, Bravo A, Ramírez A, Morreale de Escobar G, Were F, Merlino G, Vidal M, Jorcano JL.

J Clin Invest. 1999 Jun;103(11):1587-95.

32.

Modulation of cell proliferation by cytokeratins K10 and K16.

Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB, Jorcano JL.

Mol Cell Biol. 1999 Apr;19(4):3086-94.

33.

Keratin intermediate filament dynamics in cell heterokaryons reveals diverse behaviour of different keratins.

Paramio JM, Casanova ML, Alonso A, Jorcano JL.

J Cell Sci. 1997 May;110 ( Pt 9):1099-111.

34.

[Splenic-cutaneous angiomatosis, hypersplenism and renal malformation].

Grasa MP, Fatás JA, Alfonso JA, Abascal M, Domínguez M, Casanova ML, Valero N, Carapeto FJ.

Actas Dermosifiliogr. 1981 Sep-Oct;72(9-10):455-58. Spanish. No abstract available.

PMID:
7337006

Supplemental Content

Loading ...
Support Center